Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Annexin A2 As a Potential Biomarker for Venous Thromboembolism in Sickle Cell Anemia

Ugochi O. Ogu, Athena Starlard-Davenport, Alana Smith, Jacqueline J. Harris, Keesha Roach, Kenneth I. Ataga, Steven Goodman

Blood (2024) 144 (Supplement 1): 5306.

https://doi.org/10.1182/blood-2024-200260

Published: 2024

Journal Articles

Myeloma-Associated Adipocytes Exhibit Reduced Adipogenic Gene Expression and Delipidation

Heather Fairfield, MS, Elizabeth J Harris, Carolyne Falank, PhD, Michaela Reagan, PhD

Blood (2017) 130 (Supplement 1): 1768.

https://doi.org/10.1182/blood.V130.Suppl_1.1768.1768

Published: 2017

Journal Articles

Mutations in succinate dehydrogenase B ( SDHB ) enhance neutrophil survival independent of HIF-1α expression

Robert Jones, Kate E. McDonald, Joseph A. Willson, Bart Ghesquière, David Sammut, Eleni Daniel, Alison J. Harris, Amy Lewis, A. A. Roger Thompson, Rebecca S. Dickinson, Tracie Plant, Fiona Murphy, Pranvera Sadiku, Brian G. Keevil, Peter Carmeliet, Moira K. B. Whyte, John Newell-Price, Sarah R. Walmsley

Blood (2016) 127 (21): 2641–2644.

https://doi.org/10.1182/blood-2016-02-696922

Published: 2016

Includes: Supplemental data

Journal Articles

Pharmacological Inhibitors of LSD1 Promote Differentiation of Myeloid Leukemia Cells through a Mechanism Independent of Histone Demethylation

James T Lynch, PhD, Gary J Spencer, PhD, William J Harris, PhD, Alba Maiques-Díaz, PhD, Filippo Ciceri, PhD, Xu Huang, PhD, Tim C P Somervaille, PhD FRCP, FRCPath

Blood (2014) 124 (21): 267.

https://doi.org/10.1182/blood.V124.21.267.267

Published: 2014

Journal Articles

Glucose metabolism impacts the spatiotemporal onset and magnitude of HSC induction in vivo

James M. Harris, Virginie Esain, Gregory M. Frechette, Lauren J. Harris, Andrew G. Cox, Mauricio Cortes, Maija K. Garnaas, Kelli J. Carroll, Claire C. Cutting, Tahsin Khan, Philip M. Elks, Stephen A. Renshaw, Bryan C. Dickinson, Christopher J. Chang, Michael P. Murphy, Barry H. Paw, Matthew G. Vander Heiden, Wolfram Goessling, Trista E. North

Blood (2013) 121 (13): 2483–2493.

https://doi.org/10.1182/blood-2012-12-471201

Published: 2013

Includes: Supplemental data

Journal Articles

Pharmacological Inhibition or Genetic Knockdown of Kdm1a (Lsd1 or Aof2) Induces Differentiation of MLL Acute Myeloid Leukaemia Stem Cells

William J Harris, BSc, Xu Huang, PhD, James T Lynch, PhD, Tim Somervaille, PhD MRCP FRCPath

Blood (2011) 118 (21): 58.

https://doi.org/10.1182/blood.V118.21.58.58

Published: 2011

Journal Articles

Metabolism-Induced Reactive Oxygen Species and Hif1α-Mediated Gene Regulation Control the Timing and Magnitude of Hematopoietic Stem Cell Induction

James M Harris, Lauren J. Harris, Andrew G Cox, Maija K Garnaas, Gregory M Frechette, Mauricio Cortes, Claire C Cutting, Michael C Dovey, PhD, Barry H. Paw, M.D., Ph.D., Matthew Vander Heiden, MD, PhD, Wolfram Goessling, MD, PhD, Trista E. North, Ph.D.

Blood (2011) 118 (21): 1266.

https://doi.org/10.1182/blood.V118.21.1266.1266

Published: 2011

Journal Articles

Cancerous inhibitor of PP2A (CIP2A) at diagnosis of chronic myeloid leukemia is a critical determinant of disease progression

Claire M. Lucas, Robert J. Harris, Athina Giannoudis, Mhairi Copland, Joseph R. Slupsky, Richard E. Clark

Blood (2011) 117 (24): 6660–6668.

https://doi.org/10.1182/blood-2010-08-304477

Published: 2011

Includes: Supplemental data

Journal Articles

Glucose Catabolism with Resultant Formation of Reactive Oxygen Species and Local Hypoxia Modulates the Induction and Expansion of Hematopoietic Stem Cells

James M Harris, Lauren J Harris, Michael C Dovey, PhD, Claire C Cutting, Barry H Paw, M.D., Ph.D., Matthew G Vander Heiden, Wolfram Goessling, MD, PhD, Trista E North, PhD

Blood (2010) 116 (21): 408.

https://doi.org/10.1182/blood.V116.21.408.408

Published: 2010

Journal Articles

Nilotinib concentration in Cell Lines and CML CD34+ Cells Is Not Mediated by Active Uptake or Efflux by Major Drug Transporters

Joanne Mountford, PhD, Andrea Davies, Niove E Jordanides, Athina Giannoudis, Claire M Lucas, Sophia Hatziieremia, Robert J Harris, Heather G Jorgensen, Munir Pirmohamed, Tessa L Holyoake, Richard E Clark

Blood (2008) 112 (11): 3205.

https://doi.org/10.1182/blood.V112.11.3205.3205

Published: 2008

Journal Articles

Effective dasatinib uptake may occur without human organic cation transporter 1 (hOCT1): implications for the treatment of imatinib-resistant chronic myeloid leukemia

Athina Giannoudis, Andrea Davies, Claire M. Lucas, Robert J. Harris, Munir Pirmohamed, Richard E. Clark

Blood (2008) 112 (8): 3348–3354.

https://doi.org/10.1182/blood-2007-10-116236

Published: 2008

Journal Articles

STAT3 Signaling in Donor-Derived CD4 + T-Cells Plays a Critical Role in the Induction of Acute and Chronic GVHD in Murine Models of alloBMT.

Vedran Radojcic, MD, Maria A. Pletneva, BSc, Hung-Rong Yen, MD, Timothy J. Harris, Bsc, Drew M. Pardoll, MD, PhD, Charles G. Drake, MD, PhD, Leo Luznik, MD

Blood (2007) 110 (11): 2179.

https://doi.org/10.1182/blood.V110.11.2179.2179

Published: 2007

Journal Articles

Characterisation of Nilotinib Transport in Chronic Myeloid Leukaemia Cells.

Andrea Davies, PhD, Athina Giannoudis, PhD, Claire M. Lucas, BSc, Robert J. Harris, PhD, Paul W. Manley, PhD, Munir Pirmohamed, PhD, FRCP, FRCP(E), Richard E. Clark, MA, MD, FRCP, FRCPat

Blood (2007) 110 (11): 2364.

https://doi.org/10.1182/blood.V110.11.2364.2364

Published: 2007

Journal Articles

Unlike Imatinib, Dasatinib Uptake into Chronic Myeloid Leukaemia Cells Is Independent of hOCT1 Expression.

Athina Giannoudis, PhD, Andrea Davies, PhD, Claire M. Lucas, BSc, Robert J. Harris, PhD, Munir Pirmohamed, PhD, FRCP, FRCP(E), Richard E. Clark, MA, MD, FRCP, FRCPat

Blood (2007) 110 (11): 3458.

https://doi.org/10.1182/blood.V110.11.3458.3458

Published: 2007

Journal Articles

Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells

Monica V. Goldberg, Charles H. Maris, Edward L. Hipkiss, Andrew S. Flies, Lijie Zhen, Rubin M. Tuder, Joseph F. Grosso, Timothy J. Harris, Derese Getnet, Katharine A. Whartenby, Dirk G. Brockstedt, Thomas W. Dubensky, Jr, Lieping Chen, Drew M. Pardoll, Charles G. Drake

Blood (2007) 110 (1): 186–192.

https://doi.org/10.1182/blood-2006-12-062422

Published: 2007

Journal Articles

A Multicenter Phase II Study of Perifosine (KRX-0401) Alone and in Combination with Dexamethasone (Dex) for Patients with Relapsed or Relapsed/Refractory Multiple Myeloma (MM).

Blood (2006) 108 (11): 3582.

https://doi.org/10.1182/blood.V108.11.3582.3582

Published: 2006

Journal Articles

A Phase I, Multi-Center, Dose Escalation Study of Atiprimod in Patients with Refractory or Relapsed Multiple Myeloma (MM).

Michael Wang, MD, Moshe Talpaz, MD, Sundar Jagannath, MD, Asher Alban Chanan-Khan, MD, Raymond Alexanian, MD, Donna M. Weber, MD, Maria Gavino, R.N., Zeev Estrov, MD, Pamela J. Harris, MD, Donald Picker, MD, Robert L. Schlossman, MD, Pierfrancesco Tassone, MD, Kenneth C. Anderson, MD, Nikhil C. Munshi, MD

Blood (2005) 106 (11): 111.

https://doi.org/10.1182/blood.V106.11.111.111

Published: 2005

Journal Articles

Over-Expression of c-Abl in CLL Cells Is Associated with Advanced Disease, and Contributes to CLL-Cell Survival through Activation of NF-kB.

Ke Lin, PhD, Robert J. Harris, PhD, Sally Dennett, John C. Cawley, MD, PhD, Mirko Zuzel, MD, Joseph R. Slupsky, PhD

Blood (2005) 106 (11): 1191.

https://doi.org/10.1182/blood.V106.11.1191.1191

Published: 2005

Journal Articles

Chronic Lymphocytic Leukaemia Patients with a Biallelic Deletion of 13q14 Have a More Favourable Profile of Prognostic Factors Compared with Cases That Have a Monoallelic 13q14 Deletion.

Andrew R. Pettitt, PhD, MRCPath, Chloe J. Emmens, Ke Lin, PhD, Robert J. Harris, PhD

Blood (2005) 106 (11): 5019.

https://doi.org/10.1182/blood.V106.11.5019.5019

Published: 2005

Journal Articles

CLL, but not normal, B cells are dependent on autocrine VEGF and α 4 β 1 integrin for chemokine-induced motility on and through endothelium

Kathleen J. Till, David G. Spiller, Robert J. Harris, Haijuan Chen, Mirko Zuzel, John C. Cawley

Blood (2005) 105 (12): 4813–4819.

https://doi.org/10.1182/blood-2004-10-4054

Published: 2005

NARROW

Annexin A2 As a Potential Biomarker for Venous Thromboembolism in Sickle Cell Anemia

Myeloma-Associated Adipocytes Exhibit Reduced Adipogenic Gene Expression and Delipidation

Mutations in succinate dehydrogenase B ( SDHB ) enhance neutrophil survival independent of HIF-1α expression

Pharmacological Inhibitors of LSD1 Promote Differentiation of Myeloid Leukemia Cells through a Mechanism Independent of Histone Demethylation

Glucose metabolism impacts the spatiotemporal onset and magnitude of HSC induction in vivo

Pharmacological Inhibition or Genetic Knockdown of Kdm1a (Lsd1 or Aof2) Induces Differentiation of MLL Acute Myeloid Leukaemia Stem Cells

Metabolism-Induced Reactive Oxygen Species and Hif1α-Mediated Gene Regulation Control the Timing and Magnitude of Hematopoietic Stem Cell Induction

Cancerous inhibitor of PP2A (CIP2A) at diagnosis of chronic myeloid leukemia is a critical determinant of disease progression

Glucose Catabolism with Resultant Formation of Reactive Oxygen Species and Local Hypoxia Modulates the Induction and Expansion of Hematopoietic Stem Cells

Nilotinib concentration in Cell Lines and CML CD34+ Cells Is Not Mediated by Active Uptake or Efflux by Major Drug Transporters

Effective dasatinib uptake may occur without human organic cation transporter 1 (hOCT1): implications for the treatment of imatinib-resistant chronic myeloid leukemia

STAT3 Signaling in Donor-Derived CD4 + T-Cells Plays a Critical Role in the Induction of Acute and Chronic GVHD in Murine Models of alloBMT.

Characterisation of Nilotinib Transport in Chronic Myeloid Leukaemia Cells.

Unlike Imatinib, Dasatinib Uptake into Chronic Myeloid Leukaemia Cells Is Independent of hOCT1 Expression.

Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells

A Multicenter Phase II Study of Perifosine (KRX-0401) Alone and in Combination with Dexamethasone (Dex) for Patients with Relapsed or Relapsed/Refractory Multiple Myeloma (MM).

A Phase I, Multi-Center, Dose Escalation Study of Atiprimod in Patients with Refractory or Relapsed Multiple Myeloma (MM).

Over-Expression of c-Abl in CLL Cells Is Associated with Advanced Disease, and Contributes to CLL-Cell Survival through Activation of NF-kB.

Chronic Lymphocytic Leukaemia Patients with a Biallelic Deletion of 13q14 Have a More Favourable Profile of Prognostic Factors Compared with Cases That Have a Monoallelic 13q14 Deletion.

CLL, but not normal, B cells are dependent on autocrine VEGF and α 4 β 1 integrin for chemokine-induced motility on and through endothelium

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only